About Epixis
Epixis is a company based in Paris (France) founded in 2003 was acquired by VBI Vaccines in September 2011. Epixis operates in a competitive market with competitors including VBI Vaccines, HilleVax, Eiger BioPharmaceuticals, Intercell and Sinovac, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
VBI Vaccines
(Sep 15, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Epixis
Detailed funding history for Epixis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Epixis
Epixis has secured backing from 1 investor. Prominent investors backing the company include VBI Vaccines.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
Locked | Locked | Locked |
Investor details for Epixis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epixis
Investment portfolio details for Epixis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epixis
Detailed financials for Epixis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epixis Comparisons
Peer comparison for Epixis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epixis
Epixis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VBI Vaccines, HilleVax, Eiger BioPharmaceuticals, Intercell and Sinovac, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
|
| Locked | Locked | Locked |
A norovirus vaccine is developed for infection prevention.
|
|
| Locked | Locked | Locked |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases, including antigens and adjuvants, were developed.
|
|
| Locked | Locked | Locked |
Vaccines against various infectious diseases are developed by Sinovac.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for various eye disorders are developed.
|
Detailed competitors of Epixis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epixis
Complete news archive for Epixis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epixis
Epixis was founded in 2003.
Epixis is headquartered in Paris, France.
Epixis was founded in 2003 in Paris, France, as a biotechnology company. Recombinant virus-like particles were utilized in the development of immunotherapies targeting hepatitis C. The eVLP platform technology supported vaccine programs for this disease. A partnership with VBI Vaccines was formed in 2010 for a cytomegalovirus initiative. Acquisition by VBI Vaccines took place in 2011.
Epixis's top competitors include HilleVax, Eiger BioPharmaceuticals and VBI Vaccines.
Epixis has 1 investor. Key investors include VBI Vaccines.